← Back to Search

Empowering Conversations for Postpartum Care (DECORUM Trial)

N/A
Recruiting
Led By Samuel DeMaria Jr., MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients of age 18 or greater with a singleton fetus of at least 37 weeks of gestation that present in spontaneous labor, for induction of labor, or augmentation of labor
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postpartum day 1
Awards & highlights

DECORUM Trial Summary

This trial will share data on disparities in obstetric anesthesia care with minority groups to reduce mistrust and empower patients to make informed decisions.

Who is the study for?
This trial is for pregnant individuals, 18 or older, with a single baby at least 37 weeks along and in the first stage of labor. They must be admitted to The Mount Sinai Hospital's labor unit and agree to an epidural. It excludes those in severe pain, having a cesarean after trying labor, with blood clotting issues or on certain medications.Check my eligibility
What is being tested?
The study aims to improve understanding and trust in obstetric anesthesia care among underserved minorities by sharing information about disparities. It seeks to empower these patients through education during their admission for childbirth.See study design
What are the potential side effects?
Since this intervention involves conversations rather than medical treatments, there are no direct physical side effects expected from participating in this trial.

DECORUM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older, pregnant with one baby at least 37 weeks along, and in labor or about to be induced.

DECORUM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postpartum day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and postpartum day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
DECORUM Questionnaire

DECORUM Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ConversationExperimental Treatment1 Intervention
Scripted interaction
Group II: No ConversationActive Control1 Intervention
Control Group

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
861 Previous Clinical Trials
525,176 Total Patients Enrolled
Daniel Katz, MDStudy ChairIcahn School of Medicine at Mount Sinai
5 Previous Clinical Trials
709 Total Patients Enrolled
Samuel DeMaria Jr., MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

Media Library

Disparities Conversation Clinical Trial Eligibility Overview. Trial Name: NCT05260242 — N/A
Postpartum Research Study Groups: Conversation, No Conversation
Postpartum Clinical Trial 2023: Disparities Conversation Highlights & Side Effects. Trial Name: NCT05260242 — N/A
Disparities Conversation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05260242 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers have been recruited to participate in this medical trial?

"Affirmative, the clinical trial is actively seeking participants. This research project was originally published on March 28th 2022 and has recently been updated on March 31st 2022. The goal of this study is to recruit 500 individuals from a single site."

Answered by AI

Is the enrollment period for this trial currently open to volunteers?

"Affirmative, the details published on clinicaltrials.gov reveal that this trial is indeed seeking participants. First posted on March 28th 2022, the study's last update was made a few days later. 500 patients must be recruited for participation at one medical facility."

Answered by AI
~4 spots leftby Jun 2024